Tay-Sachs disease.
Fernandes Filho JA, Shapiro BE.
Arch Neurol. 2004 Sep;61(9):1466-8. doi: 10.1001/archneur.61.9.1466.
[Tay-Sachs disease (beta-hexosaminidase alpha-chain deficiency)].
Okada S, Taniike M.
Ryoikibetsu Shokogun Shirizu. 1998;(19 Pt 2):394-6.
[Sandhoff disease (beta-hexosaminidase alpha-chain deficiency)].
Taniike M, Okada S.
Ryoikibetsu Shokogun Shirizu. 1998;(19 Pt 2):397-9.
GM2 gangliosidosis with a motor neuron disease phenotype: clinical heterogeneity of hexosaminidase deficiency disease.
Federico A.
Adv Exp Med Biol. 1987;209:19-23. doi: 10.1007/978-1-4684-5302-7_4.
Deficiency of Glucocerebrosidase Activity beyond Gaucher Disease: PSAP and LIMP-2 Dysfunctions.
Pavan E, Peruzzo P, Cattarossi S, Bergamin N, Bordugo A, Sechi A, Scarpa M, Biasizzo J, Colucci F, Dardis A.
Int J Mol Sci. 2024 Jun 16;25(12):6615. doi: 10.3390/ijms25126615.
Discovery of beta-hexosaminidase A deficiency in Tay-Sachs disease.
Okada S, O'Brien JS.
Adv Genet. 2001;44:61-6. doi: 10.1016/s0065-2660(01)44071-5.
Hexosaminidase--pseudodeficiency?
Kappler J, Gieselmann V, Propping P.
Am J Hum Genet. 1990 Nov;47(5):880-2.
Inheritance of the enzyme defect in a new hexosaminidase deficiency disease.
Johnson WG, Chutorian AB.
Ann Neurol. 1978 Nov;4(5):399-403. doi: 10.1002/ana.410040503.
[Schindler disease/Kanzaki disease].
Kanzaki T.
Nihon Rinsho. 1995 Dec;53(12):2982-7.
The beta-hexosaminidase deficiency disorders: development of a clinical paradigm in the mouse.
Tifft CJ, Proia RL.
Ann Med. 1997 Dec;29(6):557-61. doi: 10.3109/07853899709007482.
